Late Loss Versus Target Lesion Revascularization: What Is the Difference in the Numbers?
Long-Term Clinical Outcomes Following Drug-Eluting and Bare Metal Stenting in Massachusetts
Letter by Kereiakes et al regarding article, "Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern". Circulation. 2007 Oct 16;116(16):e389; author reply e390.
Clinical and angiographic outcomes in diabetics from the ENDEAVOR IV trial: randomized comparison of zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease. JACC Cardiovasc Interv. 2009 Oct;2(10):967-76.
Clinical and angiographic results with the next-generation resolute stent system: a prospective, multicenter, first-in-human trial. JACC Cardiovasc Interv. 2009 Oct;2(10):977-85.